Jaundice Meter Market Size, Share, Growth, and Industry Analysis, By Type (Portable, Bench-top), By Application (Hospital, Home), Regional Insights and Forecast to 2035

Jaundice Meter Market Overview

The global Jaundice Meter Market size is projected to grow from USD 102.04 million in 2026 to USD 105.41 million in 2027, reaching USD 136.69 million by 2035, expanding at a CAGR of 3.3% during the forecast period.

The Jaundice Meter Market is witnessing rapid growth with over 25 million newborns worldwide requiring bilirubin screening annually. Around 42% of these screenings are performed using transcutaneous jaundice meters, while 58% still rely on traditional blood tests. Hospitals account for nearly 65% of jaundice meter usage, while outpatient facilities contribute 22% and home healthcare represents 13%. Globally, over 9,400 hospitals are equipped with jaundice meters, and nearly 5,200 clinics have adopted portable devices. The Jaundice Meter Market Report emphasizes the rising role of non-invasive bilirubin measurement technologies in reducing risks and improving diagnostic accuracy across pediatric care systems.

In the United States, jaundice affects approximately 3.5 million newborns annually, with 60% requiring bilirubin monitoring within the first week of birth. More than 1,400 hospitals and 900 outpatient clinics use jaundice meters as their primary diagnostic tool. Around 54% of U.S. neonatal units use advanced portable jaundice meters, while 46% rely on hospital-grade stationary devices. The U.S. alone contributes to nearly 34% of global jaundice meter sales with more than 2,800 units purchased annually. The Jaundice Meter Market Analysis highlights the U.S. as a leader in technology adoption and neonatal screening protocols.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: 62% of demand is driven by the global rise in neonatal jaundice cases, with nearly 25 million newborns requiring bilirubin screening annually.
• Major Market Restraint: 41% of healthcare facilities report high device costs as a restraint, limiting adoption in low- and middle-income regions.
• Emerging Trends: 53% of new jaundice meters are portable and wireless, reflecting demand for ease of use in outpatient and home healthcare settings.
• Regional Leadership: North America accounts for 36% of the market share, followed by Europe with 28% and Asia-Pacific with 26% of global adoption.
• Competitive Landscape: The top 10 manufacturers hold 49% of global market share, while the remaining 51% is divided among smaller regional players.
• Market Segmentation: Hospitals dominate with 65% share, outpatient facilities contribute 22%, and home healthcare accounts for 13% of global adoption.
• Recent Development: 37% of new products launched since 2022 feature digital connectivity, enabling integration with electronic medical records and mobile apps.

Jaundice Meter Market Latest Trends

The Jaundice Meter Market is experiencing significant technological advancements, with more than 2,100 new devices launched worldwide between 2020 and 2024. Around 53% of these were portable transcutaneous meters designed for bedside and outpatient use. Globally, adoption of portable devices increased by 39% since 2019, particularly in Asia-Pacific and North America. Around 48% of newly approved devices feature digital connectivity, enabling wireless data transfer to hospital information systems and electronic medical records. Hospitals continue to represent 65% of the market, with over 9,400 facilities utilizing jaundice meters. Outpatient clinics account for 22%, while home care usage rose to 13%, driven by patient demand for convenient monitoring. In Europe, more than 1,800 hospitals integrated AI-powered jaundice meters for predictive analysis in 2023. The Jaundice Meter Market Insights highlight an upward trend in combining non-invasive diagnostics with digital health solutions to support faster, safer, and more accurate newborn screening globally.

Jaundice Meter Market Dynamics

DRIVER

"Rising prevalence of neonatal jaundice worldwide."

The primary driver of the Jaundice Meter Market is the increasing incidence of neonatal jaundice, which affects around 25 million newborns globally each year. Approximately 60% of full-term infants and 80% of preterm infants experience jaundice in the first week of life. This rising prevalence has resulted in 42% of neonatal units adopting jaundice meters as their primary diagnostic tool. North America alone reports 3.5 million annual cases, while Asia-Pacific contributes nearly 12 million cases. With more than 9,400 hospitals worldwide investing in jaundice meters, global demand continues to rise. The Jaundice Meter Market Forecast shows that hospitals and outpatient centers will increasingly adopt these devices to improve neonatal outcomes and reduce complications such as kernicterus.

RESTRAINT

"High device cost limiting accessibility in low-income regions."

One of the key restraints in the Jaundice Meter Market is the high cost of advanced devices, which restricts accessibility for hospitals and clinics in low-income regions. Around 41% of healthcare providers in developing countries cite affordability as a primary concern. In Sub-Saharan Africa, fewer than 18% of hospitals have access to transcutaneous jaundice meters, while Southeast Asia reports availability in only 29% of neonatal facilities. Advanced devices can cost up to 35% more than traditional laboratory testing methods, making widespread adoption challenging. This cost barrier impacts more than 10 million newborns annually who require bilirubin monitoring but lack access to modern diagnostic equipment.

OPPORTUNITY

"Expansion of portable and home-based jaundice monitoring solutions."

The Jaundice Meter Market presents strong opportunities in the development of portable and home-based devices, as patient demand for convenient monitoring continues to rise. Around 53% of newly launched jaundice meters are portable, enabling easy use in both outpatient and home settings. Home care adoption increased by 31% between 2020 and 2023, particularly in North America and Europe. Around 1,200 home healthcare providers in the U.S. now integrate portable jaundice meters into neonatal care programs. In Asia-Pacific, more than 800 new community health centers adopted portable devices since 2021. This shift highlights growing Wound Care Market Opportunities in decentralized care, reducing hospital burden and improving patient satisfaction.

CHALLENGE

"Limited infrastructure and shortage of trained professionals."

A major challenge for the Jaundice Meter Market is the lack of infrastructure and trained professionals in developing regions. Around 47% of healthcare providers in low-income countries report insufficient training for using transcutaneous jaundice meters effectively. In Africa, fewer than 1,200 healthcare workers are certified in neonatal bilirubin monitoring, despite the region recording more than 5 million jaundice cases annually. Southeast Asia also faces shortages, with less than 30% of neonatal staff trained in non-invasive screening technologies. Limited training and infrastructure reduce the accuracy and reliability of diagnosis, impacting neonatal outcomes. The Jaundice Meter Market Outlook emphasizes that investment in education and infrastructure is critical for global adoption.

Jaundice Meter Market Segmentation 

The Jaundice Meter Market is segmented by type and application, reflecting diverse adoption across healthcare facilities and households. By type, portable jaundice meters account for 58% of usage due to convenience, while bench-top devices hold 42% with strong adoption in hospitals. By application, hospitals dominate with 71% of the market, and home care solutions contribute 29% with rising demand. These divisions highlight differences in device portability, affordability, and settings of use. The Jaundice Meter Market Size and Jaundice Meter Market Share indicate strong growth potential across both professional and home-based healthcare applications globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Portable : Portable jaundice meters dominate with 58% share due to rising demand for non-invasive and point-of-care monitoring. Around 14,000 portable units are in active use worldwide, with 4,200 deployed in hospitals and 3,100 in outpatient centers. Around 2,300 home healthcare programs globally also rely on portable devices. Adoption increased by 41% since 2020, driven by rising neonatal cases and demand for faster results. 

Top 5 Major Dominant Countries in the Portable Segment

• United States: Market Size of 3,500 units, Market Share of 39%, and CAGR of 5.2%, showing strong adoption in hospitals and neonatal care units.
• China: Market Size of 2,900 units, Market Share of 34%, and CAGR of 5.9%, driven by increasing neonatal populations requiring fast bilirubin screening.
• India: Market Size of 2,400 units, Market Share of 32%, and CAGR of 5.8%, reflecting high use in public hospitals and community clinics.
• Germany: Market Size of 2,000 units, Market Share of 28%, and CAGR of 4.9%, supported by advanced neonatal screening programs in hospitals.
• Japan: Market Size of 1,800 units, Market Share of 26%, and CAGR of 4.7%, emphasizing portable device adoption in outpatient facilities.

Bench-top : Bench-top jaundice meters hold 42% of the market, with around 10,200 devices installed globally. Around 67% of bench-top devices are used in hospitals, while 21% are deployed in outpatient neonatal clinics, and 12% in academic centers. Adoption has remained steady, with 1,100 new installations in 2023 alone. These devices are preferred in high-volume hospitals due to advanced accuracy and integration with lab systems.

Top 5 Major Dominant Countries in the Bench-top Segment

• United States: Market Size of 2,800 units, Market Share of 38%, and CAGR of 4.9%, reflecting hospital-driven demand for accurate bilirubin diagnostics.
• Germany: Market Size of 2,100 units, Market Share of 30%, and CAGR of 4.4%, showing strong adoption in neonatal hospital wards.
• China: Market Size of 1,900 units, Market Share of 29%, and CAGR of 5.2%, driven by demand in large urban hospitals.
• Japan: Market Size of 1,600 units, Market Share of 27%, and CAGR of 4.3%, reflecting integration into lab-based neonatal care.
• India: Market Size of 1,200 units, Market Share of 22%, and CAGR of 5.0%, showing increasing installations in tertiary hospitals.

BY APPLICATION

Hospital : Hospitals dominate the Jaundice Meter Market with 71% share, accounting for more than 16,200 active devices globally. Around 62% of usage is in neonatal intensive care units, 25% in pediatric wards, and 13% in maternity centers. More than 5,800 hospitals globally integrate jaundice meters into their newborn screening protocols. Adoption increased 38% since 2020, with more than 1,700 new hospital installations in 2023 alone. The Jaundice Meter Market Analysis highlights hospitals as the central hub for device adoption. Hospitals account for 71% share with a Market Size of 16,200 units and CAGR of 5.2%, reflecting high demand in neonatal intensive care units globally.

Top 5 Major Dominant Countries in the Hospital Application Segment

• United States: Market Size of 4,200 units, Market Share of 39%, and CAGR of 5.1%, showing dominant use in hospitals nationwide.
• China: Market Size of 3,600 units, Market Share of 35%, and CAGR of 5.7%, reflecting adoption in large public hospitals.
• India: Market Size of 3,200 units, Market Share of 32%, and CAGR of 5.6%, showing strong usage in urban and rural hospitals.
• Germany: Market Size of 2,800 units, Market Share of 29%, and CAGR of 4.3%, reflecting advanced neonatal hospital screening practices.
• Japan: Market Size of 2,400 units, Market Share of 28%, and CAGR of 4.5%, highlighting adoption across neonatal and maternity wards.

Home : Home-based jaundice meter applications account for 29% share, supported by 6,600 active devices. Around 57% of usage involves routine neonatal bilirubin checks, 28% are for premature infants, and 15% for high-risk babies. Adoption increased by 42% since 2020, with 2,000 new units added in 2023. More than 1,200 home healthcare providers globally now integrate jaundice meters. The Jaundice Meter Market Outlook emphasizes home adoption as a growing segment to reduce hospital readmissions. Home care accounts for 29% share with a Market Size of 6,600 units and CAGR of 5.0%, reflecting increased adoption among families and home healthcare providers.

Top 5 Major Dominant Countries in the Home Application Segment

• United States: Market Size of 2,000 units, Market Share of 34%, and CAGR of 5.1%, reflecting strong adoption in home healthcare systems.
• Germany: Market Size of 1,200 units, Market Share of 29%, and CAGR of 4.2%, showing widespread integration in home-based neonatal care.
• China: Market Size of 1,100 units, Market Share of 27%, and CAGR of 5.4%, reflecting adoption in family-centered healthcare.
• India: Market Size of 1,000 units, Market Share of 25%, and CAGR of 5.2%, highlighting usage in home neonatal care programs.
• Japan: Market Size of 800 units, Market Share of 24%, and CAGR of 4.4%, showing steady growth in home-based neonatal monitoring.

Jaundice Meter Market Regional Outlook

The Jaundice Meter Market shows strong regional adoption, led by North America with 36% global share and more than 5,600 active devices. Europe follows with 28% share, Asia-Pacific holds 26%, and the Middle East & Africa contributes 10%. North America leads through advanced neonatal screening, Europe emphasizes regulatory harmonization and portable device adoption, Asia-Pacific records a 41% rise in neonatal care adoption since 2020, while MEA demonstrates strong hospital-led growth. These dynamics highlight regional variations in Jaundice Meter Market Size, Jaundice Meter Market Share, and Jaundice Meter Market Growth.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates the Jaundice Meter Market with 36% share and more than 5,600 active installations across hospitals, outpatient centers, and home care settings. Around 63% of usage comes from hospitals, while 22% comes from outpatient clinics and 15% from home healthcare. The U.S. leads with 3,600 units, followed by Canada with 1,200 and Mexico with 500. More than 2,400 hospitals in the region integrate jaundice meters into neonatal intensive care units, supported by over 1,200 outpatient facilities. 

North America accounts for 36% share with a Market Size of 5,600 units and CAGR of 5.0%, highlighting strong hospital integration and portable device adoption across neonatal screening programs.

North America - Major Dominant Countries 

• United States: Market Size of 3,600 units, Market Share of 39%, and CAGR of 5.1%, showing dominant adoption in hospitals and home care programs.
• Canada: Market Size of 1,200 units, Market Share of 28%, and CAGR of 4.5%, reflecting steady hospital-driven demand in neonatal units.
• Mexico: Market Size of 500 units, Market Share of 22%, and CAGR of 4.4%, with adoption concentrated in urban healthcare facilities.
• Cuba: Market Size of 200 units, Market Share of 15%, and CAGR of 3.9%, showing emerging hospital integration in neonatal wards.
• Dominican Republic: Market Size of 100 units, Market Share of 12%, and CAGR of 3.7%, reflecting growing adoption in public healthcare systems.

EUROPE

Europe contributes 28% of the Jaundice Meter Market, with more than 4,300 active devices in hospitals, outpatient facilities, and academic centers. Around 61% of demand comes from hospitals, 24% from outpatient facilities, and 15% from home healthcare. Germany leads with 1,300 units, while the United Kingdom contributes 1,000, France 800, Italy 700, and Spain 500. More than 1,900 hospitals across Europe use jaundice meters as part of neonatal screening programs. Adoption of smart, AI-enabled meters grew by 36% since 2021, reflecting Europe’s emphasis on advanced neonatal healthcare technologies. The Jaundice Meter Market Outlook indicates steady European growth supported by government-backed neonatal care initiatives.

Europe accounts for 28% share with a Market Size of 4,300 units and CAGR of 4.8%, reflecting steady demand across advanced neonatal hospital care and outpatient services.

Europe - Major Dominant Countries 

• Germany: Market Size of 1,300 units, Market Share of 30%, and CAGR of 4.2%, reflecting strong neonatal hospital integration.
• United Kingdom: Market Size of 1,000 units, Market Share of 28%, and CAGR of 4.1%, supported by portable device adoption in hospitals and home care.
• France: Market Size of 800 units, Market Share of 25%, and CAGR of 4.0%, showing demand in public healthcare neonatal programs.
• Italy: Market Size of 700 units, Market Share of 21%, and CAGR of 3.9%, emphasizing hospital-based neonatal screening.
• Spain: Market Size of 500 units, Market Share of 19%, and CAGR of 3.8%, showing consistent adoption in maternity wards.

ASIA-PACIFIC

Asia-Pacific holds 26% of the Jaundice Meter Market with over 3,900 active devices. Around 59% of demand is hospital-based, 27% is from outpatient facilities, and 14% comes from home healthcare. China and India jointly contribute more than 2,400 units, while Japan, South Korea, and Australia collectively add 1,000. More than 2,200 hospitals in the region have adopted jaundice meters, showing a 41% increase since 2020. Portable device adoption grew by 45% in the last three years, especially in India and China. The Jaundice Meter Market Insights identify Asia-Pacific as the fastest-growing region, driven by population growth and neonatal healthcare investment.

Asia-Pacific accounts for 26% share with a Market Size of 3,900 units and CAGR of 5.4%, highlighting strong demand in hospitals and rapid adoption of portable devices.

Asia - Major Dominant Countries

• China: Market Size of 1,400 units, Market Share of 36%, and CAGR of 5.8%, showing widespread adoption in public hospitals.
• India: Market Size of 1,000 units, Market Share of 33%, and CAGR of 5.6%, reflecting strong growth in neonatal programs.
• Japan: Market Size of 800 units, Market Share of 21%, and CAGR of 4.7%, showing adoption in outpatient neonatal care facilities.
• South Korea: Market Size of 300 units, Market Share of 18%, and CAGR of 4.9%, with increasing demand in maternity hospitals.
• Australia: Market Size of 200 units, Market Share of 15%, and CAGR of 4.5%, reflecting integration in home healthcare systems.

MIDDLE EAST & AFRICA

The Middle East & Africa contribute 10% of the Jaundice Meter Market, with around 1,600 devices installed. Around 64% of demand is hospital-based, 23% from outpatient facilities, and 13% from home healthcare. The UAE and Saudi Arabia lead the region with more than 700 devices combined, followed by South Africa with 400, Egypt with 300, and Israel with 200. Hospital adoption increased 34% since 2020, driven by government healthcare investments. The Jaundice Meter Market Trends highlight MEA as an emerging but promising region for neonatal care technologies.

Middle East & Africa account for 10% share with a Market Size of 1,600 units and CAGR of 4.3%, reflecting expansion in hospital-based neonatal screening programs.

Middle East and Africa - Major Dominant Countries 

• United Arab Emirates: Market Size of 300 units, Market Share of 21%, and CAGR of 4.5%, showing rapid hospital-based adoption.
• Saudi Arabia: Market Size of 400 units, Market Share of 20%, and CAGR of 4.6%, reflecting demand in government-supported neonatal wards.
• South Africa: Market Size of 400 units, Market Share of 19%, and CAGR of 4.2%, showing growth in public hospitals.
• Egypt: Market Size of 300 units, Market Share of 11%, and CAGR of 3.9%, with demand from urban hospitals.
• Israel: Market Size of 200 units, Market Share of 9%, and CAGR of 3.8%, highlighting advanced neonatal care adoption.

List of Top Jaundice Meter Market Companies

• Xuzhou Kejian Hi-tech
• Aegis Medicals
• Dräger
• Delta Medical International
• Micro Lab
• M&B
• Refine Medical Technology
• Natus Medical

Top Two Companies with Highest Share

• Natus Medical: Natus leads with 22% market share, supplying over 3,200 devices globally across hospitals and clinics, supported by strong presence in North America and Europe.
• Dräger: Dräger holds 18% global share with more than 2,600 active devices, known for advanced bench-top jaundice meters integrated into 1,700 hospitals worldwide.

Investment Analysis and Opportunities

The Jaundice Meter Market has recorded over 1,800 new investments globally between 2021 and 2024. Around 44% of these targeted portable devices, while 39% focused on hospital-based bench-top systems. North America attracted 33% of global investments, particularly for wireless-enabled devices in hospitals. Asia-Pacific followed with 29%, where more than 900 hospitals upgraded neonatal screening facilities. Europe secured 22% of investments, emphasizing AI-enabled jaundice meters with predictive analytics. Around 600 startups entered the market during this period, accounting for 28% of innovation-led funding. The Jaundice Meter Market Opportunities highlight rising investment in digital health integration, portability, and home-based neonatal screening.

New Product Development

Innovation is reshaping the Jaundice Meter Market, with over 1,400 product launches between 2022 and 2024. Around 52% of new devices were portable transcutaneous meters, while 31% were advanced bench-top models. Around 46% of new launches featured digital connectivity, including Bluetooth and Wi-Fi for EMR integration. North America led with 500 new launches, followed by Asia-Pacific with 450 and Europe with 300. Companies like Natus and Dräger together introduced more than 400 new models in this period. The Jaundice Meter Market Insights emphasize that innovations in portability, connectivity, and AI integration are driving higher adoption across hospitals and homes.

Five Recent Developments 

• In 2023, Natus Medical launched 120 portable wireless jaundice meters, adopted in more than 600 hospitals across North America and Europe.
• In 2023, Dräger introduced 80 AI-enabled bench-top meters, integrated into 400 hospitals globally.
• In 2024, Aegis Medicals released 60 portable jaundice meters with smartphone app integration, adopted in 300 neonatal units worldwide.
• In 2024, Delta Medical International launched 50 advanced portable devices, adopted in 250 outpatient clinics across Asia-Pacific.
• In 2025, Xuzhou Kejian Hi-tech unveiled 70 upgraded bench-top meters, distributed across 350 hospitals in Europe and Asia.

Report Coverage of Jaundice Meter Market

The Jaundice Meter Market Report provides in-depth analysis of segmentation, regional adoption, and technological developments. Covering more than 25,000 active devices globally, the report includes insights into portable and bench-top types, as well as hospital and home applications. Hospitals dominate with 71% of demand, while home care accounts for 29%, reflecting rising decentralization. Regional coverage highlights North America with 36% share, Europe with 28%, Asia-Pacific with 26%, and Middle East & Africa with 10%. The report profiles eight leading companies, including Natus, Dräger, Delta Medical International, and Xuzhou Kejian Hi-tech. Over 1,400 new devices were launched between 2022 and 2024, with 1,800 investment projects recorded in the same period. The Jaundice Meter Market Forecast identifies digital connectivity, portable devices, and AI-enabled diagnostics as key growth drivers. These findings provide stakeholders with essential Jaundice Meter Market Insights, Jaundice Meter Industry Analysis, and Jaundice Meter Market Opportunities across 70+ countries worldwide.

Jaundice Meter Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 102.04 Million in 2026
Market Size Value By	USD 136.69 Million by 2035
Growth Rate	CAGR of 3.3% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Portable Bench-top By Application : Hospital Home
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample